Accounts Receivables - West Pharmaceutical Services Inc (NYSE:WST) - Alpha Spread

West Pharmaceutical Services Inc
NYSE:WST

Watchlist Manager
West Pharmaceutical Services Inc Logo
West Pharmaceutical Services Inc
NYSE:WST
Watchlist
Price: 296.985 USD -1.23%
Market Cap: 22B USD
Have any thoughts about
West Pharmaceutical Services Inc?
Write Note

West Pharmaceutical Services Inc
Accounts Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

West Pharmaceutical Services Inc
Accounts Receivables Peer Comparison

Comparables:
TMO
DHR
MTD
A
IQV

Competitive Accounts Receivables Analysis
Latest Figures & CAGR of Competitors

Company Accounts Receivables CAGR 3Y CAGR 5Y CAGR 10Y
West Pharmaceutical Services Inc
NYSE:WST
Accounts Receivables
$479.4m
CAGR 3-Years
0%
CAGR 5-Years
8%
CAGR 10-Years
9%
Thermo Fisher Scientific Inc
NYSE:TMO
Accounts Receivables
$9.4B
CAGR 3-Years
15%
CAGR 5-Years
18%
CAGR 10-Years
13%
Danaher Corp
NYSE:DHR
Accounts Receivables
$3.3B
CAGR 3-Years
-8%
CAGR 5-Years
-2%
CAGR 10-Years
-1%
Mettler-Toledo International Inc
NYSE:MTD
Accounts Receivables
$634.7m
CAGR 3-Years
2%
CAGR 5-Years
5%
CAGR 10-Years
4%
Agilent Technologies Inc
NYSE:A
Accounts Receivables
$1.2B
CAGR 3-Years
3%
CAGR 5-Years
7%
CAGR 10-Years
3%
IQVIA Holdings Inc
NYSE:IQV
Accounts Receivables
$3.3B
CAGR 3-Years
13%
CAGR 5-Years
6%
CAGR 10-Years
13%

See Also

What is West Pharmaceutical Services Inc's Accounts Receivables?
Accounts Receivables
479.4m USD

Based on the financial report for Jun 30, 2024, West Pharmaceutical Services Inc's Accounts Receivables amounts to 479.4m USD.

What is West Pharmaceutical Services Inc's Accounts Receivables growth rate?
Accounts Receivables CAGR 10Y
9%

Over the last year, the Accounts Receivables growth was -10%.

Back to Top